Metastatic gastric cancer treatment: a little slow but worthy progress. - Wikidata - awgldk - TriplyDB

Metastatic gastric cancer treatment: a little slow but worthy progress.

Metastatic gastric cancer treatment: a little slow but worthy progress.

http://www.wikidata.org/entity/Q38075499

about

Targeted therapy for advanced gastric cancer: A review of current status and future prospects Gastric cancer: current and evolving treatment landscape Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway Decline of serum CA724 as a probable predictive factor for tumor response during chemotherapy of advanced gastric carcinoma Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer.Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer.Metastatic spread in patients with gastric cancer.miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway.RNAi-mediated silencing of NOX4 inhibited the invasion of gastric cancer cells through JAK2/STAT3 signaling.Traditional Chinese medicine Ka-Sai-Ping suppresses the growths of gastric cancers via induction of autophagy.Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer.Celastrus orbiculatus extracts induce apoptosis and inhibit invasion by targeting the maspin gene in human gastric adenocarcinoma cells.Antiproliferative effects of the CDK6 inhibitor PD0332991 and its effect on signaling networks in gastric cancer cells.Metastatic adenocarcinomas of the stomach or esophagogastric junction (UICC stage IV) are not always a palliative situation: a retrospective analysis.Extracts of Celastrus orbiculatus exhibit anti-proliferative and anti-invasive effects on human gastric adenocarcinoma cells.

P2860

Q26774138-8A292840-69F6-4985-AC3C-C33E55803B9B Q28073757-B83BA20C-6716-4D29-BB18-BB23E92E4007 Q33779037-AE93537D-B7EA-4ECC-B3EC-B6702284E317 Q33960305-0D8CB018-F0F1-42F5-8FE7-7E7870A0D815 Q34130176-DAEEEF50-764A-4F63-94AC-D8AD72E89EF0 Q36306641-92005BB8-6FBB-46EA-9539-0DBF259F7D6E Q36905898-CCE600A2-0D43-4CA9-9FCC-19B9ACD2BA7A Q37588449-4A847BD7-093F-4917-83E8-438EC07D3C7C Q38971368-7EBD4B0B-3CC5-4127-AC83-5CB2B041E331 Q44034196-B78AE368-D6AD-4B4A-9B7E-D5E5A712C0B3 Q47135130-21DD5FA5-93E6-416F-ACFE-BF0456A76A84 Q47899728-72EBF9BC-7ED5-44E8-93F5-7C92E9C64DF4 Q49757927-4799893B-24C9-49D8-87D4-ED6DC570B2D2 Q50047971-1C69C85D-EBFA-4119-97D6-1461FAD1D2DD Q50761729-F8BD27A2-2E72-44FD-8BF9-1416ECFDC71B Q54185651-4054DBD7-DEBE-4775-8D55-3B64B0DE7229

P2860

Metastatic gastric cancer treatment: a little slow but worthy progress.

http://www.wikidata.org/entity/Q38075499

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Metastatic gastric cancer treatment: a little slow but worthy progress.

@en

type

label

Metastatic gastric cancer treatment: a little slow but worthy progress.

@en

prefLabel

Metastatic gastric cancer treatment: a little slow but worthy progress.

@en

P1433

Q38075499-DE659858-12AC-413C-A96A-2B7A8787CA79

P1476

Q38075499-AF36EA39-3C16-45B7-9379-C4F12FB2803B

P2093

Q38075499-0DB45AB7-7529-40A4-A23E-6460ADA10153

Q38075499-3638885F-9E36-4A94-B466-D53E74F58314

P2860

Q38075499-097BDA62-4E96-422F-834B-369A68D49012

Q38075499-0B8C10B9-989B-4BAB-BF71-D3B2B497091A

Q38075499-0C8DB918-EE91-4140-BEB2-7CCE1626FC2B

Q38075499-0CAAA301-84FD-4A8F-BFE7-CCBC2030DD37

Q38075499-0EE5DE75-41B6-4708-AE9A-371DA65EB852

Q38075499-11438E00-1112-4917-B1DF-DC5212FDBD0B

Q38075499-118832C6-98D2-4FAE-9887-A85CBBE3C461

Q38075499-12E58AB5-56B7-4954-92ED-60B732980459

Q38075499-1731F5A7-91E4-42F1-A3B8-F3201B1B0BD8

Q38075499-177F4E44-55E1-488A-A68C-B8559B976525

P2888

Q38075499-8A2728B0-D715-4198-9697-B539E479A520

P304

Q38075499-49C70D22-DD51-46A1-820F-F3FA0DADDB10

P31

Q38075499-76B43D60-1AC7-4F28-9834-FAB4C76BF395

P356

Q38075499-6A24A480-0832-4720-893D-D37DE6F55F63

P433

Q38075499-1DFCC231-9E44-45B7-B780-502401322BB3

P478

Q38075499-A196C770-B4CC-45D2-B9F5-33D1CFC40734

P577

Q38075499-DED79143-B6C2-440F-ABF6-617E198B77A0

P6179

Q38075499-1D577183-9D51-4AD8-9009-47E4B09732EA

P698

Q38075499-4B0F312F-C4DC-4015-8ECF-9B798112B2F9

P356

S12032-013-0464-4

P1433

Medical Oncology

P1476

Metastatic gastric cancer treatment: a little slow but worthy progress.

@en

P2093

Bert H O'Neil

http://www.w3.org/2001/XMLSchema#string

Ozkan Kanat

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Cancer statistics, 2012

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Tumorigenesis and the angiogenic switch

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

P2888

s12032-013-0464-4

P304

464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-013-0464-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013179361

http://www.w3.org/2001/XMLSchema#string

P698

23335104

http://www.w3.org/2001/XMLSchema#string